In Nature this week: athletes' gut microbiomes, nanopore metagenomic sequencing approach to diagnosing infectious diseases, and more.
University of California, San Diego researchers investigate how skin care products influence the skin microbiome, Scientific American reports.
Business Insider reports that uBiome halted the sale and testing of its SmartJane and SmartGut tests.
The partners will offer Onegevity's GutBio assay, which integrates metagenomic sequencing with AI-based personalized recommendations to improve gut health, in Japan.
The Guardian reports that delivery mode seems to affect the makeup of infants' gut microbiomes.
In a study of microbial genome data, researchers noted that many horizontal gene transfer events appeared to occur between different sites within the human body.
The researchers said a microbiome-based test could expand the number of individuals who are screened for the disease.
Researchers identified a handful of microbes associated with spontaneous preterm birth, and highlighted host immune protein levels with potential ties to the condition.
The company shared details of its methods and results of some internal experiments but has been met with skepticism by members of the research community.
Microba currently offers a direct-to-consumer gut microbiome profile product and plans to release additional products for clinical and research use cases.
The Centers for Disease Control and Prevention estimates more people get sick and die from drug-resistant germs than previously thought, the Washington Post reports.
According to the Associated Press, three universities and a healthcare institution are sharing a gift of $1 billion.
New rules seek to limit the type of scientific and medical research that can be used to guide public health regulations, the New York Times reports.
In Nature this week: FreeHi-C approach simulates Hi-C data from interacting genome fragments, and more.